Correction to: Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients
Clin Rheumatol
.
2022 Dec;41(12):3925.
doi: 10.1007/s10067-022-06412-8.
Authors
Yael Pri-Paz Basson
1
2
,
Oshrat E Tayer-Shifman
1
2
,
Rawand Naser
1
,
Shelly Tartakover Matalon
2
3
,
Oded Kimhi
4
,
Raz Gepstein
5
,
Tamar Halperin
6
,
Tomer Ziv-Baran
2
,
Amit Ziv
7
,
Roma Parikh
8
,
Shaye Kivity
9
10
,
Yair Levy
2
11
Affiliations
1
Rheumatology Unit, Meir Medical Center, Kfar Saba, Israel.
2
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
3
The Autoimmune Research Laboratory, Meir Medical Center, Kfar Saba, Israel.
4
Department of Internal Medicine A, Meir Medical Center, Kfar Saba, Israel.
5
Department of Ophthalmology, Meir Medical Center, Kfar Saba, Israel.
6
Department of Infectious Diseases, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.
7
Pediatric Rheumatology Unit, Meir Medical Center, Kfar Saba, Israel.
8
Department of Human Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
9
Rheumatology Unit, Meir Medical Center, Kfar Saba, Israel. kivitys@gmail.com.
10
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. kivitys@gmail.com.
11
Department of Internal Medicine E, Meir Medical Center, Kfar Saba, Israel.
PMID:
36251175
PMCID:
PMC9828834
DOI:
10.1007/s10067-022-06412-8
No abstract available
Publication types
Published Erratum